SIGN-UP NOW!
Click to become a VoiceAmerica Member for Free!
Between the Synapse
Thursday at 10 AM Pacific
December 11, 2014: The Biggest Threat to HealthCare
The Ebola media storm that hit US shores this fall fortunately outweighed its actual impact. While the virus remains extremely deadly in Sub-Saharan Africa, only two patients are known to have acquired the disease on United States soil, both in the treatment of an Ebola patient in a Dallas hospital. Conversely, the media rarely covers a class of disease that on an annual basis kills almost 100,000 Americans, infects millions more and costs over $30 billion. Healthcare Associated Infections (HAI's) such as MRSA and C. diff, are infections that approximately 1 out of every 20 patients acquire
Tune in
Thursday at 10 AM Pacific Time on VoiceAmerica Variety Channel
Featured Guests
Xenex CEO Morris Miller is responsible for the Company's overall business strategy and oversight of day-to-day operations. He is also the founder of Sequel and Cutstone Ventures, where he invests in and acts as an advisor to numerous startup and established technology companies. Previously, Morris was co-founder and President/CEO of Rackspace Hosting, Inc. which now has more than 175,000 customers, over $1 billion in annual revenue, and a market cap in excess of $4 billion. He is an alumnus of Phillips Exeter Academy, The University of Texas at Austin and The Dedman School of Law at Southern Methodist University
(www.xenex.com)
@XenexDisinfect
Xenex co-founder & Chief Scientific Officer Mark Stibich oversees the Company's scientific research, product development, facility assessments, and protocol design. An inventor on multiple patents, Stibich leads new technology development and meets frequently with infection prevention representatives at healthcare facilities, helping them understand and solve their infection control problems. Dr. Stibich holds a doctoral degree from the Johns Hopkins University School of Public Health, a Masters in Health Science, also from Johns Hopkins, and a bachelor’s degree from Yale University.
(www.xenex.com)
@XenexDisinfect
Nancy Carralla is the Executive Director of the C Diff Foundation, a nonprofit organization created to educate about, and advocate for, C. difficile infection prevention, treatment, and environmental safety worldwide. Founded by Nancy in 2012 after personally surviving two serious bouts with the infection acquired in her capacity as a nurse practitioner, the Foundation seeks to reduce the number of newly diagnosed Clostridium difficile cases and preventable deaths.
(http://www.cdifffoundation.org)
Eden is a powerful, non-mercury, germ killing, xenon based UV lamp form of UV light that generates high intensity pulses.
